Literature DB >> 23158681

Clinical outcomes after implantation of a new hydrophobic acrylic toric IOL during routine cataract surgery.

Amy L Sheppard1, James S Wolffsohn2, Uday Bhatt2, Peter C Hoffmann2, Andreas Scheider2, Werner W Hütz2, Sunil Shah2.   

Abstract

PURPOSE: To assess the clinical outcomes after implantation of a new hydrophobic acrylic toric intraocular lens (IOL) to correct preexisting corneal astigmatism in patients having routine cataract surgery.
SETTING: Four hospital eye clinics throughout Europe.
DESIGN: Cohort study.
METHODS: This study included eyes with at least 0.75 diopter (D) of preexisting corneal astigmatism having routine cataract surgery. Phacoemulsification was performed followed by insertion and alignment of a Tecnis toric IOL. Patients were examined 4 to 8 weeks postoperatively; uncorrected distance visual acuity (UDVA), corrected distance visual acuity, manifest refraction, and keratometry were measured. Individual patient satisfaction with uncorrected vision and the surgeon's assessment of ease of handling and performance of the IOL were also documented. The cylinder axis of the toric IOL was determined by dilated slitlamp examination.
RESULTS: The study enrolled 67 eyes of 60 patients. Four to 8 weeks postoperatively, the mean UDVA was 0.15 logMAR ± 0.17 (SD) and the UDVA was 20/40 or better in 88% of eyes. The mean refractive cylinder decreased significantly postoperatively, from -1.91 ± 1.07 D to -0.67 ± 0.54 D. No significant change in keratometric cylinder was observed. The mean absolute IOL misalignment from the intended axis was 3.4 degrees (range 0 to 12 degrees). The good UDVA resulted in high levels of patient satisfaction.
CONCLUSION: Implantation of the new toric IOL was an effective, safe, and predictable method to manage corneal astigmatism in patients having routine cataract surgery.
Copyright © 2012 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23158681     DOI: 10.1016/j.jcrs.2012.08.055

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  Introduction of a Toric Intraocular Lens to a Non-Refractive Cataract Practice: Challenges and Outcomes.

Authors:  Clare Kirwan; John M Nolan; Jim Stack; Ian Dooley; Johnny Moore; Tara Cb Moore; Stephen Beatty
Journal:  Int J Ophthalmol Clin Res       Date:  2016-05-25

2.  Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification.

Authors:  Jonathan C Lake; Gustavo Victor; Gerry Clare; Gustavo Jm Porfírio; Ashleigh Kernohan; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

3.  Comparison of the clinical outcomes of Eyecryl and Tecnis® toric intraocular lenses: A real-world study.

Authors:  Mithun Thulasidas; Ajita Sasidharan; Balam Pradeep
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

4.  Comparison of clinical outcomes of toric intraocular lens, Precizon vs Tecnis: a single center randomized controlled trial.

Authors:  Na Yeon Jung; Dong Hui Lim; Sung Soon Hwang; Joo Hyun; Tae-Young Chung
Journal:  BMC Ophthalmol       Date:  2018-11-09       Impact factor: 2.209

5.  Improving the Toric Intraocular Lens Calculation by Considering Posterior Corneal Astigmatism and Surgically-induced Corneal Astigmatism.

Authors:  Chang Ho Yoon; Mee Kum Kim
Journal:  Korean J Ophthalmol       Date:  2018-08

6.  Clinical Outcomes after Uncomplicated Cataract Surgery with Implantation of the Tecnis Toric Intraocular Lens.

Authors:  Wojciech Lubiński; Beata Kaźmierczak; Jolanta Gronkowska-Serafin; Karolina Podborączyńska-Jodko
Journal:  J Ophthalmol       Date:  2016-02-28       Impact factor: 1.909

7.  Comparison of Two Toric IOLs with Different Haptic Design: Optical Quality after 1 Year.

Authors:  Kata Miháltz; Michael Lasta; Michael Burgmüller; Pia Veronika Vécsei-Marlovits; Birgit Weingessel
Journal:  J Ophthalmol       Date:  2018-02-11       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.